Come September, patients living with Rosacea will have a new treatment option.  The FDA just cleared a new topical medication, called brimonidine alpha-2 adrenergic agonist, specifically indicated for those afflicted with rosacea.  The medicine works by constricting the dilated blood vessels that cause the facial redness commonly associated with rosacea and lasts for 12 hours.

This entry was posted on Wednesday, August 28th, 2013 at 3:15 pm and is filed under Healthy Skin. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.